Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2022 08:00 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

London, United Kingdom, July 26, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...
July 21, 2022 10:33 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

London, United Kingdom, July 21, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...
July 20, 2022 20:20 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

London, United Kingdom, July 20, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention,...
May 31, 2022 08:30 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders

London, United Kingdom, May 31, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”), an innovative biotechnology company focused on the prevention, detection, and...
May 17, 2022 09:00 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Introduces New Board of Directors, Announces Members

London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Introduces New Board of Directors, Announces Members London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs...
May 09, 2022 09:01 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research

London, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs (“Virax” or the “Company”), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral...
April 28, 2022 08:00 ET | Source: Virax Biolabs Group Limited

Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

London, United Kingdom, April 28, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Group Limited (“Virax” or the “Company”) is pleased to announce the appointment of Jason D. Davis to the role of Chief...